Join us at Innovation for Health 2023 🇳🇱 Next week, Triall team members Ray and Arno will be attending Innovation for Health (#I4H) in Rotterdam. I4H brings together 900+ Life Sciences innovators, entrepreneurs, and thought leaders to discuss the future of healthcare. https://t.co/eoBOdszqpi

New staking pool is closing soon 💎 Our #staking pool is closing in 1 week. The 8% APR pool is available on #BSC and runs for 100 days. New to $TRL staking? - Whitelist yourself https://t.co/sCHML0vDPn - Read the guide https://t.co/wwU8d6uVVp Staking powered by @FerrumNetwork https://t.co/3uWEbxGQQx

Announcing the next community AMA 📺💬 On March 30 at 12:00 UTC, the Triall team will host its 13th #community #AMA on @YouTube, answering live and pre-submitted questions from the audience. 📬 Submit your questions today & stand to win $50 in TRL at https://t.co/O9vzIlonMJ https://t.co/JTunEj60ob

Triall at BIO-Europe🇨🇭 Over the past 3 days, Triall team members Hadil and Ray attended #BIOEuropeSpring in Basel, Switzerland. The event proved to be a great venue for partnering discussions with over 20 forward-thinking clinical CROs and potential strategic partners. https://t.co/60iuco43fO

Absolutely! ✅ Ray is doing a brilliant job here representing our company and generating sales. Stay tuned.

According to a study by IQVIA, decentralised clinical trials (DCTs) can realise a 78% reduction in patient recruitment timelines. Triall offers a range of integrated #DCT tools that promote #patientengagement throughout the study. Source: https://t.co/eLdQEKhhn0 https://t.co/aacd9hBRsH

In the news: there’s a worrying amount of fraud in medical research 🗞️ According to a recent article published in The Economist, as much as 1 in 50 research papers includes results which are unreliable because of fabrication, plagiarism, or serious errors. A large amount of these fabricated papers claim to report on clinical trials. Common patterns among fraudulent clinical trial papers include unusually big treatment effects, peculiar participant drop-out rates, or the same data appearing in different trial reports. Triall aims to make clinical research more reliable and verifiable using blockchain. Using our blockchain anchoring API, researchers can de-risk the likelihood of data manipulation by making trial-related data, documents, and processes tamper-resistant. Source: https://www.economist.com/science-and-technology/2023/02/22/there-is-a-worrying-amount-of-fraud-in-medical-research #blockchainforhealth #TRL

70% of study participants live 2+ hours away from a research site 🏥 Triall’s platform offers the latest in #decentralised and #mobile technologies to promote patient convenience and help sponsors access a larger and more diverse patient pool. Source: https://t.co/7Rq1FNipEc https://t.co/DB2vKf2od4

Announcing the AMA winners 🏆📺💬 Last week, Triall hosted its 12th monthly community AMA live on YouTube. Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team. AMA winner list @neodufour @xmotions @Defi58 @Pandalucu66 @Idee01 How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: https://www.youtube.com/live/h5ywT0h65oo?feature=share When is the next AMA? Our next community AMA will be hosted by the end of this month (date to be announced). #blockchainforhealth #TRL

Fact of the day 🔍 According to the IQVIA Institute, 1.8 million people participated in #clinicaltrials across 2022. The last 4 years have seen record-breaking numbers of participants in clinical research. Source: https://t.co/MWFOpOEGM6 #blockchainforhealth #TRL https://t.co/lbvuGWmzVl

New staking pool is live 💎 Our new #staking pool is now open for staking! The 8% APR pool is available on #BSC and runs for 100 days. New to $TRL staking? - Whitelist yourself https://t.co/sCHML0wbEV - Read the guide https://t.co/wwU8d6vtKX Staking powered by @FerrumNetwork https://t.co/2vMfwEUlGI

New staking pool opening tomorrow 💎 Get ready to stake! A new #staking pool is opening on March 4 at 6PM UTC. The 8% APR pool will launch on #BSC and runs for 100 days. New to $TRL staking? - Whitelist yourself https://t.co/sCHML0vDPn - Read the guide https://t.co/wwU8d6uVVp https://t.co/57CNIE8M9G

New staking pool this Saturday 💎 A new #staking pool is opening on March 4 at 18:00 UTC. The BSC Holder 7 (8% APR) pool will launch on #BSC and runs for 100 days. New to $TRL staking? - Whitelist yourself https://t.co/sCHML0vDPn - Read the guide https://t.co/wwU8d6uVVp https://t.co/VKSdmD2DHH

And we’re live once again! 🚨📺💬 Tune in to our $TRL-focused Triall community AMA 👇 https://www.youtube.com/watch?v=h5ywT0h65oo

Decentralised clinical trials (#DCTs) can realise a 54% reduction in protocol deviations. Triall offers a range of DCT tools that help #clinicaltrial professionals with maintaining protocol #compliance throughout all of their key activities. Source: https://t.co/V2KplkVRVN https://t.co/qBMeZGfGqH

Announcing our next community AMA 📺💬 On February 27 at 15:30 UTC, Triall will host its 12th #community #AMA on @YouTube, focusing exclusively on questions related to $TRL. Submit your questions today & stand to win $50 in TRL at https://t.co/OOTX2I0PWp https://t.co/aKpEeqk4py

79% of healthcare professionals have a #digital #transformation strategy in place or are working towards one. A growing body of organisations is embracing emerging technologies to remain competitive and resilient to changing business conditions. Source: https://t.co/5xlQWj8kSS https://t.co/TkAwvRrXwm

Triall token economics explained 🌐 Want to learn more about the role of $TRL in the Triall ecosystem? We’ve updated our animated explainer video to align with our improved #tokeneconomics. 👉 Check out the new video: https://t.co/ohLwPQJGUr #blockchainforhealth #TRL

Phase 3 clinical trials collect 3x more data compared to 10 years ago (3.6M data points on average). Triall’s eClinical platform facilitates proactive study management & oversight by uniting all data streams in a single integrated platform. Source: https://t.co/Fu4deP4T2d https://t.co/NOYQmti1KG

Announcing this month’s AMA winners 🏆📺💬 Last week, Triall hosted its 11th monthly community AMA live on YouTube. Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team. AMA winner list @Andromedamin @Algojali @Aghaspar10 @sunsun77 @Justice321 How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: https://www.youtube.com/live/VZF5RnCDSbk?feature=share When is the next AMA? Gear up for our next AMA, which will focus exclusively on $TRL (date to be announced). Start submitting your questions here: bit.ly/TRLvidAMA12 #blockchainforhealth #TRL

How Triall is using AI 🤖 Electronic health records (#EHR) have long remained underutilised in clinical research. With our #AI tool, researchers can automatically structure & import EHRs into their database, saving significant time & resources. 👉Info: https://t.co/AU4H5FMMFr https://t.co/Njd2Nqixx2

Triall featured in Applied Clinical Trials 🗞️ Our CEO Hadil Es-Sbai has written an article for Applied Clinical Trials (@Clin_Trials). The article explains how Self-Sovereign Identity (#SSI) and #blockchain can enable patient data ownership. 👉 Link: https://t.co/NlTTwgv3Lr https://t.co/9NJrE1EvKR

80% of site staff are optimistic about the future operating environment for #clinicaltrials. Research site optimism is significantly related to the degree to which site staff feels that sponsors request, value, and apply feedback from the site. Source: https://t.co/ujR4glVfp6 https://t.co/fd5DgNNO1K

Hi @Wesvv11, Thank you for sharing your thoughts and ideas. We highly appreciate you taking the time to verbalise your concerns and are happy to address these topics. We are indeed putting a lot of focus and effort on onboarding new clinical trials and furthering our blockchain & SSI roadmap. Traction in this domain will directly drive the future success of $TRL in the following ways: 1. New clinical trial contracts trigger our $TRL token economics (more info); 2. New clinical trial contracts trigger our $TRL burn accelerator (more info); 3. New clinical trial contracts (and associated customers) ensure the sustainability of Triall and thereby $TRL; 4. Our blockchain & SSI roadmap is one of our core USPs and continues to attract industry stakeholders such as Mayo Clinic who express interest in partnering, co-development, and other synergies. Our SSI applications will be instrumental in realising the decentralised and patient-centric data exchange environment that we are planning for, and in which $TRL will have broad utility. Now to answer your questions: ⁃ Software solutions are well-received and praised by clinical operations professionals for their intuitiveness, flexibility, and interoperability (being able to conduct all of your clinical trial activities in one single platform is one of our key strengths). We continue to further develop and strengthen our collaboration with Crucial Data Solutions, Sphereon, Mayo Clinic, and other strategic partners to extend upon our current offering and find new ways to collaborate and engage with our target customer groups. ⁃ $TRL is one of the key building blocks of our vision, which is building towards a federated data ecosystem where patients (and healthy volunteers) can provide and monetise their health data. As explained above, Triall and $TRL know several interdependencies where success in the clinical domain leads to success in the crypto domain (and vice versa). We intend to further engage and collaborate with the $TRL community across 2023, for instance by involving community members in sales and marketing activities. ⁃ While we won’t speculate on token price, we will continue to build traction in sales, marketing, and product development to benefit Triall and $TRL. Examples include strategic partnerships, media coverage, and product updates. We’ve also planned to publish a new public roadmap this quarter. We think it makes sense to fully dedicate our next AMA session to $TRL-related questions. To facilitate community input I’ve already opened up the question portal here: https://bit.ly/TRLvidAMA12 Kind regards, The Triall Team

New month, new AMA, we’re live once again! 🚨📺💬 Tune in to this month’s live #community #AMA 👇 https://t.co/mBYIJa6f9i

70% of site staff believe that conducting clinical trials has become much more difficult over the past five years. The most commonly reported issues include staffing challenges, study budgets, and protocol complexity. Source: https://t.co/x9C1wGYqMV #blockchainforhealth #TRL https://t.co/jRaMU12Bge

Announcing our next community AMA 📺💬 On January 31 at 13:00 UTC, Triall will host its 11th #community #AMA on @YouTube, answering both live and pre-submitted questions from the Triall community. Submit your questions today & stand to win $50 in TRL at https://t.co/t9S01SWiMn https://t.co/9b2U2pXpOd

95% of sponsors & CROs have initiatives in place to address the operational challenges that originated from the rapid adoption of decentralised trial methods. Top priorities include reducing site burden and improving data sharing & collaboration. Source: https://t.co/AcdgSajn2q https://t.co/E2A0JQE6bL

In the news: only 1 of 25 cancer drug developers fairly included minority patients. Despite policy efforts to improve #patientdiversity, under-representation of women, older adults, and racial & ethnical minorities remains a persistent problem. Link: https://t.co/MlOsbqpyQe 🧵

Only 56% of sponsors & CROs report decentralised clinical trials (DCTs) had a positive impact on patient convenience & retention. This is because DCTs often introduce multiple patient-facing applications, thereby adding complexity for patients. Source: https://t.co/XokpNHsffB https://t.co/Xj0RcuqMfJ

Decentralising clinical research: the implications of blockchain and SSI After 2 decades of #eClinical innovation, we’ve arrived at the next wave of #decentralisation. Read how #blockchain & #SSI can provide patients with more ownership over their data: https://t.co/Ik7otUpKYp

According to Veeva, 87% of sponsors and CROs are using or planning to use decentralized clinical trials (DCTs) within 12 months. Triall offers a range of purpose-built DCT tools as a fully-integrated part of its end-to-end eClinical platform. Source: https://t.co/DlSpDsGFUe https://t.co/LFsQqyCs2z

Launching the new Triall website 👩🏽‍💻 We’re thrilled to announce our new website! Our redesigned #website helps you navigate all our #eClinical products, including EDC, ePRO, eConsent, eTMF, CTMS, virtual visits, wearable integration, and more. 👉 Link: https://t.co/Y80dvOVTv2 https://t.co/8rr4jQ6r1L

Announcing the AMA winners 🏆📺💬 Last month, Triall hosted its 10th monthly community AMA live on YouTube. Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team. AMA winner list @alts_crypto @Umrsha @Felix_BL @Chris15_y @OK_Renegade How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: youtube.com/watch?v=6qAp41EdMCA When is the next AMA? Our next video AMA will be hosted by the end of this month. 🗣 Help us spread the news on Twitter: https://twitter.com/triallofficial/status/1610622632881262593?s=20&t=psVWmmdoZjhIDofGtK-TJw #blockchainforhealth #TRL

300 New Molecular Entities (NMEs) are expected to be approved in 2022-2026*. The influx of NMEs demonstrates the need for reliable & cost-efficient clinical trials. Triall's software platform supports all therapeutic areas, trial types & trial phases. *Source: IQVIA Institute https://t.co/V4OlCGcjau

End of the year message by Hadil 🎄 In this video, Triall CEO Hadil walks you through our highlights of 2022 while also providing a brief outlook on 2023. Happy holidays! 👉📺 Video link: https://t.co/CbjUOcEwdU

Our last AMA of 2022 📺💬 Want to learn more about our objectives for 2023? Join our last #community #AMA of the year (and 10th edition in this series), which will take place on Dec 22 at 3PM UTC. Submit your questions today & stand to win $50 in TRL at https://t.co/AgQ8kSVHWe https://t.co/KPvM8yW32y

Decentralised Clinical Trials (#DCTs) can realise a 78% reduction in recruiting time, measured by time from first patient in (FPI) to last patient in (LPI). Triall offers a range of DCT tools that promote #patientengagement throughout the study. Source: https://t.co/YXvf4tXxSL https://t.co/LDBSjqtww3

Join us in the last AMA of 2022 📺💬 We invite you to join us in our last #community #AMA of the year (and 10th edition in this series), which will take place on December 22 at 15:00 UTC. Submit your questions now & stand to win $50 in TRL at https://t.co/qB0E3ZuzQA https://t.co/JTOVH40GTR

According to @TuftsCSDD, 119 protocol #deviations occur on average in a typical Phase 3 clinical trial. Triall offers an end-to-end #eClinical platform that harmonises and enforces protocol #compliance across all participating research sites. Source: https://t.co/ii6MRQxaxE https://t.co/9ZAEV7yUxe

Announcing the video AMA winners 🏆📺💬 Last week, Triall hosted its 9th monthly community AMA live on YouTube. Today, we’re happy to announce the AMA winners who posted the 5 best questions for the team. AMA winner list @Cally001 @AdiBila_111 @Defi58 @Rebecca2_14 @Faith_inChaos How do I redeem my reward? Please contact @rxvdwaal to share your BEP-20 address. Missed the live session? Check out the full recording: youtu.be/A2mWxs-JKyg When is the next AMA? Our next video AMA will be hosted by the end of this month. 🗣 Help us spread the news on Twitter: https://twitter.com/triallofficial/status/1600503415234248708?s=20&t=FML01lnqp3-AMew9JSwD9w #blockchainforhealth #TRL

According to a study by IQVIA, decentralised clinical trials (#DCTs) can realise a 54% reduction in protocol deviations. Triall offers a range of DCT tools that help maintain protocol compliance throughout all key study activities. Source: https://t.co/V2KplkEgxd https://t.co/kdb0oCLrfu

And we’re live once again! 🚨📺💬 Tune in to this month’s live video AMA 👇 https://t.co/t7VqHIHcQ5

Don’t miss tomorrow's AMA 📺💬 In our last AMA, Hadil explained how technology has shaped #clinicaltrials over the years. Tomorrow (Nov 30) at 1PM UTC, Triall will host its 9th video #AMA on YouTube. 📬 Submit your questions & stand to win $50 in TRL at https://t.co/4llVzP7HlB https://t.co/LwSykQhGHn

It has come to our attention that scammers are impersonating as admins of the group. Please be advised that triall admins and moderators will never dm first. They will never ask for any funds or tokens. Stay Safu!

The clinical trial software (#eClinical solutions) market is projected to expand at a CAGR of 13.6% from 2022 to 2030. Triall's eClinical platform is designed to serve and connect all key stakeholders involved in clinical research. Source: https://t.co/UWd8DwWAMS https://t.co/LJpMZd6tw6

Announcing the next community AMA 📺💬 On Nov 30 at 13:00 UTC, Triall will host its 9th video #AMA on @YouTube, answering both live and pre-submitted questions from the Triall #community. 📬 Submit your questions now & stand to win $50 in TRL at https://t.co/4llVzP79w3 https://t.co/N0SMxAQ5yY

💎 TRL staking closing soon 💎 Our 10% APR #staking pool on #BSC will be closing in 2 days (Nov 24) and runs for 100 days. Join other $TRL token holders who've staked more than 10 million TRL since our token launch. 👉 Start staking & earn #rewards at https://t.co/NyM5Li5v9v https://t.co/D51KCRCV7S

The average patient #dropout rate across all clinical trial types and phases is 30%. Triall offers a range of patient-facing applications that help engage and retain patients throughout the full length of a study. Source: https://t.co/U7ziAPeluw #blockchainforhealth #TRL https://t.co/PwD11jlhdS

💎 TRL staking opportunity 💎 Our 10% APR #staking pool on #BSC will be closing on Nov 24 and runs for 100 days. Join other $TRL token holders who've staked more than 10 million TRL since the launch of our token. 👉 Start staking & earn #rewards at https://t.co/NyM5Li5v9v https://t.co/s4GIVUAmyY